Professor Sanders is a clinical academic based at the University of Adelaide and Royal Adelaide Hospital. He is the Director of the Centre for Heart Rhythm Disorders at the University of Adelaide; Director of Cardiac Electrophysiology and Pacing at the Royal Adelaide Hospital; and the Group Leader for Heart Rhythm Disorders at SAHMRI.

Josephine Warren is enrolled in the second year of her PhD through Alfred Health and Monash University. Her thesis is entitled 'Enhanced Cardiac Imaging to Mitigate Future Cardiac Risk'. She completed her cardiology training at the Alfred Hospital in January 2023.

Dr. Rajan Rehan is an interventional research fellow at Royal Prince Alfred and Concord Hospital, where he is completing his NHMRC-funded PhD at the University of Sydney. His research focuses on exploring novel mechanisms and therapeutic options for patients with angina and nonobstructive coronary arteries. His preliminary work was recognised with the ANZET Early Career Research Award in 2023. Dr. Rehan intends to pursue further training in complex coronary and structural intervention. Additionally, he serves as a Clinical Lecturer at the University of Sydney, regularly engaging in medical.

Dr Paratz is an academic cardiologist from St Vincent’s Institute of Medical Research. She completed her PhD in 2023 in the field of cardiac arrest and undertook a cardiac imaging fellowship in 2023. Her research interests include cardiac arrest, big data and aviation cardiology.

MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS Director of Victorian Heart Hospital, MonashHeart & ICU, Monash Health Director of Victorian Heart Institute, Monash University Professor of Cardiology, Monash University Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023. Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations. His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. He is Chair of the Asia Pacific Cardiometabolic Consortium, President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.